Ephrin-A3/EphA2轴调控细胞代谢可塑性以增强缺氧肝细胞癌的癌症干性
该研究通过整合分析肝细胞癌(HCC)与缺氧相关的转录组和基因组图谱,发现Ephrin-A3/EphA2轴是HCC中临床相关且缺氧诱导的信号轴。在EFNA3和EPHA2敲低/过表达的HCC细胞中研究其功能与机制,结果表明该轴通过SREBP1-ACLY介导的代谢重编程促进自我更新和肿瘤起始。
要点
- EFNA3在HCC中频繁上调,其过表达与更具侵袭性的肿瘤行为相关。
- 缺氧下HIF-1α直接正向调控EFNA3表达,EphA2是EFNA3的关键下游功能介质。
- Ephrin-A3/EphA2轴通过SREBP1-ACLY介导的代谢重编程促进HCC细胞自我更新和肿瘤起始。
核心结论
- Ephrin-A3/EphA2轴是HCC细胞代谢的缺氧敏感调节因子,也是HCC起始和进展的关键驱动因素。
研究设计与样本
- 对HCC和缺氧特异的多重转录组和基因组图谱进行整合分析。
- 在EFNA3和EPHA2敲低/过表达的HCC细胞中检查Ephrin-A3/EphA2轴的功能意义和机制后果。
- 通过转录组测序、定量逆转录PCR、蛋白质印迹分析和代谢组学探究潜在下游通路。
主要发现
- EFNA3在HCC中频繁上调,其过表达与更具侵袭性的肿瘤行为相关。
- 缺氧下HIF-1α直接正向调控EFNA3表达。
- EFNA3在功能上促进HCC细胞的自我更新、增殖和迁移。
- EphA2被确定为EFNA3的关键功能性下游介质。
- Ephrin-A3/EphA2正向信号轴的功能表征显示其促进自我更新能力和肿瘤起始。
关键数值与推荐
- Ephrin-A3/EphA2轴促进SREBP1成熟,其转录靶点ACLY的表达在临床队列中与EFNA3和缺氧标志物表达显著相关。
- EPHA2和ACLY稳定敲低HCC细胞的代谢特征在脂肪酸、胆固醇和三羧酸循环代谢物谱中显示显著重叠。
- ACLY被证实介导Ephrin-A3/EphA2轴的自我更新功能。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The highly proliferative nature of hepatocellular carcinoma (HCC) frequently results in a hypoxic intratumoural microenvironment, which creates a therapeutic challenge owing to a lack of mechanistic understanding of the phenomenon. We aimed to identify critical drivers of HCC development and progression in the hypoxic microenvironment. METHODS: We performed integrative analysis of multiple transcriptomic and genomic profiles specific for HCC and hypoxia and identified the Ephrin-A3/Eph receptor A2 (EphA2) axis as a clinically relevant and hypoxia-inducible signalling axis in HCC. The functional significance and mechanistic consequences of the Ephrin-A3/EphA2 axis were examined in EFNA3- and EPHA2- knockdown/overexpressing HCC cells. The potential downstream pathways were investigated by transcriptome sequencing, quantitative reverse-transcription PCR, western blotting analysis and metabolomics. RESULTS: EFNA3 was frequently upregulated in HCC and its overexpression was associated with more aggressive tumour behaviours. HIF-1α directly and positively regulated EFNA3 expression under hypoxia. EFNA3 functionally contributed to self-renewal, proliferation and migration in HCC cells. EphA2 was identified as a key functional downstream mediator of EFNA3. Functional characterisation of the Ephrin-A3/EphA2 forward-signalling axis demonstrated a promotion of self-renewal ability and tumour initiation. Mechanistically, the Ephrin-A3/EphA2 axis promoted the maturation of SREBP1 and expression of its transcriptional target, ACLY, was significantly associated with the expression of EFNA3 and hypoxia markers in clinical cohorts. The metabolic signature of EPHA2 and ACLY stable knockdown HCC cells demonstrated significant overlap in fatty acid, cholesterol and tricarboxylic acid cycle metabolite profiles. ACLY was confirmed to mediate the self-renewal function of the Ephrin-A3/EphA2 axis. CONCLUSIONS: Our findings revealed the novel role of the Ephrin-A3/EphA2 axis as a hypoxia-sensitive modulator of HCC cell metabolism and a key contributor to HCC initiation and progression. LAY SUMMARY: Hepatocellular carcinoma (HCC) is a fast-growing tumour; hence, areas of the tumour often have insufficient vasculature and become hypoxic. The presence of hypoxia within tumours has been shown to negatively impact on the survival of patients with tumours, including HCC. Herein, we identified the Ephrin-A3/EphA2 axis as a key functional driver of tumour initiation and progression in response to hypoxia. Additionally, we showed that SREBP1-ACLY-mediated metabolic rewiring was an important downstream effector that induced cancer stemness in response to Ephrin-A3/EphA2 forward-signalling.
引用
- Husain A, Chiu YT, Sze KM, et al. Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma. J Hepatol. 2022. PMID: 35227773. doi:10.1016/j.jhep.2022.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。